Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
angiotensin/atrofija
Nuoroda įrašoma į mainų sritį
5 rezultatus
Angiotensin converting enzyme inhibitors for treating optic neuropathy or congenital optic atrophy
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a .sctn.371 national stage entry of International Application No. PCT/IB2013/001375, filed Jun. 28, 2013, which claims priority to Tunisian Patent Application No. TN 2012/0343 filed Jun. 29, 2012, the entire contents of which an
Ace inhibitors in macular degeneration
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
SUMMARY OF THE INVENTION
This invention is concerned with the use of angiotensin converting enzyme (ACE) inhibitors in the treatment of senile macular degeneration, a leading cause of visual diminution in the elderly.
BACKGROUND OF THE INVENTION
Senile macular degeneration is a poorly characterized
Treatment and prevention of Th1 and `autoimmune` diseases effected with antibiotics and/or angiotensin inhibition
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF INVENTION
It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have
Medicament
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to therapeutic agents that are angiotensin II (AII) receptor antagonists useful in the treatment of macular degeneration.
BACKGROUND OF THE INVENTION
Interruption of the renin-angiotensin system (RAS) with converting enzyme inhibitors, such as
Methods, compounds, and compositions for the treatment of musculoskeletal diseases
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This application is also related to PCT Application PCT/US14/30071, filed Mar. 15, 2014, the entire contents of which application are incorporated by reference in its entirety.
FIELD OF THE INVENTION
This invention relates to methods, compounds and compositions for the treatment of musculoskeletal
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
